ArticleCancers2022

Prevalence and Outcomes of COVID-19 among Hematology/Oncology Patients and Providers of a Community-Facing Health System during the B1.1.529 ("Omicron") SARS-CoV-2 Variant Wave.

Samuel A Kareff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.